- Home
- AMRN vs BZAI Comparison
AMRN vs BZAI Comparison
Compare AMRN & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMRN | BZAI |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | Ireland | United States |
| Employees | N/A | 254 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 336.1M | 268.9M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | BZAI |
|---|---|---|
| Price | $16.01 | $1.40 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $4.67 |
| AVG Volume (30 Days) | 78.9K | ★ 4.9M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | $239.02 |
| Revenue Next Year | $1.26 | $45.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $12.96 | $1.00 |
| 52 Week High | $20.90 | $6.76 |
Technical Indicators
Market Signals| Indicator | AMRN | BZAI |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 41.43 |
| Support Level | $13.58 | $1.03 |
| Resistance Level | $17.00 | $1.57 |
| Average True Range (ATR) | 0.66 | 0.15 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 89.83 | 1.72 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
About BZAI Blaize Holdings Inc.
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.